Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets
Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets
复制标题
三个中国 X 连锁显性低磷血症性佝偻病家系 PHEX 基因的 3 个新突变
DOI:
10.1007/s00223-007-9067-4
复制
发表时间:
2007-12-01
影响因子:
4.2
通讯作者:
Zhou, Xueying
中科院分区:
文献类型:
--
作者:
Xia, Weibo;Meng, Xunwu;Zhou, Xueying
X-linked dominant hypophosphatemia (XLH, OMIM307800), the most prevalent form of inherited rickets in humans, is a dominant disorder of phosphate homeostasis characterized by growth retardation, rachitic and osteomalacic bone disease, hypophosphatemia, and renal phosphate wasting. The gene responsible for XLH was identified by positional cloning and designated PHEX (formerly PEX) to depict a phosphate-regulating gene homologous with endopeptidases on the X chromosome. Recently, extensive mutation analysis of the PHEX gene has revealed a wide variety of gene defects in XLH. The ethnic distribution of the mutations is very widespread but only a few mutations in Chinese have been reported. To analyze the molecular basis in three unrelated Chinese families with XLH, we determined the nucleotide sequence of the PHEX gene and fibroblast growth factor 23 (FGF23) gene of affected members. The serum FGF23 concentrations of these patients with XLH were also measured. Three different novel mutations were observed in these three families: one deletion mutation c.264delG causing p.W88 X; one missense mutation c.1673C > G causing p.P558A; one nonsense mutation c.1809G > A causing p.W603 X. Serum concentration of FGF23 in XLH patients of these three families was significantly higher than normal. The results suggest that PHEX gene mutations were responsible for XLH in these patients and these mutations may contribute to a higher serum FGF23 level.